Xeltis
Pre-clinicalDevelops restorative cardiovascular implants using endogenous tissue restoration technology.
Founded
2006
Focus
CardiovascularRegenerative Medicine
About
Develops restorative cardiovascular implants using endogenous tissue restoration technology.
Funding History
2Total raised: $65M
Series C$40MGrand PharmaNov 15, 2021
Series B$25MGrand PharmaMay 15, 2019
Company Info
TypePrivate
Founded2006
LocationEindhoven, Netherlands
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
2-BBB Medicines
Pre-clinical · Leiden
Batavia Biosciences
Pre-clinical · Leiden
Bilthoven Biologicals
Pre-clinical · Bilthoven
Agendia
Pre-clinical · Amsterdam
Alloksys Life Sciences
Phase 2 · Wageningen
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile